COVID-19 Breathalyzer Test Gets Emergency Use Authorization
The FDA has authorized the InspectIR COVID-19 Breathalyzer, the first COVID-19 diagnostic test to detect SARS-CoV-2 infection through breath samples.
Stay updated with breaking news from Inspectir Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has authorized the InspectIR COVID-19 Breathalyzer, the first COVID-19 diagnostic test to detect SARS-CoV-2 infection through breath samples.
The FDA has authorized the InspectIR COVID-19 Breathalyzer, the first COVID-19 diagnostic test to detect SARS-CoV-2 infection through breath samples.
The FDA has authorized the InspectIR COVID-19 Breathalyzer, the first COVID-19 diagnostic test to detect SARS-CoV-2 infection through breath samples.
The new test may be useful for screening in doctors' offices but not yet for concerts, ball games, or other large gatherings.
A COVID-19 breathalyzer test with the ability to provide diagnostic results in three minutes has won emergency-use authorization from the U.S. Food and Drug Administration, the agency announced today.